# Teriparatide

NDC: 0548-2311
Generic name: Teriparatide
Labeler / Manufacturer: Amphastar Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20251222

FDA application: ANDA213641

## Active ingredients

- TERIPARATIDE: 250 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0548-2311"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0548-2311
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d38b470a-2e62-487b-b3e7-134d3d1958b5